Recombinant Human IL-8 Protein，His

Interleukin-8 (IL-8), a pro-inflammatory cytokine, plays a critical role in the immune response by promoting the recruitment and activation of neutrophils to sites of infection and inflammation. Initially identified as a potent chemokine in the inflammatory cascade, IL-8 is produced by various cell types, including macrophages, epithelial cells, and endothelial cells, in response to inflammatory stimuli. Its dysregulation has been implicated in numerous pathological conditions, such as chronic inflammatory diseases, autoimmune disorders, and cancer progression. The advent of recombinant DNA technology has enabled the production of IL-8 in a purified form, facilitating in-depth studies into its biological functions and therapeutic potential. Research on IL-8 recombinant protein has expanded to explore its role in modulating immune responses, the mechanisms governing its signaling pathways, and its potential applications in clinical settings, such as targeted therapies for inflammation-related diseases. Furthermore, understanding the structure-function relationships of IL-8 has opened avenues for developing IL-8 antagonists, aimed at mitigating its pathological effects. As the interest in cytokine biology continues to grow, IL-8 remains a focal point for developing novel therapeutic strategies to harness the immune response effectively while minimizing the risks associated with excessive inflammation.